Profil
Mr. Todd H.
Tobiasz is Controller at Gallus Biopharmaceuticals LLC.
Mr. Tobiasz was previously employed as a Director-Financial Planning by Sigma-Aldrich Corp., a Principal by Electronic Data Systems Corp., and a Principal by McDonnell Douglas Corp.
He received his undergraduate degree from the University of Washington and an MBA from the University of Washington.
Anciens postes connus de Todd H. Tobiasz
| Sociétés | Poste | Fin |
|---|---|---|
McDonnell Douglas Corp.
McDonnell Douglas Corp. Aerospace & DefenseElectronic Technology Manufactures aerospace and aircraft | Corporate Officer/Principal | - |
| SIGMA-ALDRICH CORPORATION | Corporate Officer/Principal | - |
Electronic Data Systems Corp.
Electronic Data Systems Corp. Information Technology ServicesTechnology Services Provides information technology and data processing services | Corporate Officer/Principal | - |
Patheon Biologics LLC
Patheon Biologics LLC BiotechnologyHealth Technology Manufactures, supplies clinical and commercial bulk biologics to the biopharmaceutical industry | Comptroller/Controller/Auditor | - |
Formation de Todd H. Tobiasz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
McDonnell Douglas Corp.
McDonnell Douglas Corp. Aerospace & DefenseElectronic Technology Manufactures aerospace and aircraft | Electronic Technology |
Sigma-Aldrich Corp.
Sigma-Aldrich Corp. Pharmaceuticals: OtherHealth Technology Produces and develops pharmaceutical drug therapy products | Health Technology |
Electronic Data Systems Corp.
Electronic Data Systems Corp. Information Technology ServicesTechnology Services Provides information technology and data processing services | Technology Services |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Patheon Biologics LLC
Patheon Biologics LLC BiotechnologyHealth Technology Manufactures, supplies clinical and commercial bulk biologics to the biopharmaceutical industry | Health Technology |
















